Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: Insights into hormonal control of adrenocortical tumorigenesis

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 9, 1998, Pages 3134-3143

  Chabre, Olivier ^a   Liakos, Panagiotis ^b   Vivier, Josiane ^a   Chaffanjon, Philippe ^a   Labat Moleur, Françoise ^a   Martinie, Monique ^a   Bottari, Serge P ^a   Bachelot, Ivan ^a   Chambaz, Edmond M ^a,b   Defaye, Geneviève ^b   Feige, Jean Jacques ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b CEA GRENOBLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CYCLIC AMP; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; HORMONE RECEPTOR; HYDROCORTISONE; INOSITOL 1,4,5 TRISPHOSPHATE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ARTICLE; CARCINOGENESIS; CASE REPORT; CONTROLLED STUDY; CUSHING SYNDROME; FEMALE; FOOD INTAKE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; TUMOR CELL;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ADULT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CUSHING SYNDROME; DNA; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYDROCORTISONE; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; RECEPTORS, CORTICOTROPIN; RECEPTORS, GASTROINTESTINAL HORMONE; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 7844237881     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.9.3134     Document Type: Article

References (42)

1. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. 1997 Propranolol therapy for ectopic β-adrenergic receptors in adrenal Cushing syndrome. N Engl J Med. 337:1429-1434.
2. Lacroix A, Bolté F, Tremblay I, et al. 1992 Gastric inhibitory polypeptide-dependent cortisol hypersecretion-a new cause of Cushing's syndrome. N Engl J Med. 327:974-980.
3. Reznik Y, Allali-Zerah V, Chayvialle J, et al. 1992 Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory peptide. N Engl J Med. 327:981-986.
4. Lacroix A, Tremblay J, Touyz R, et al. 1997 Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. J Clin Endocrinol Metab. 82:2414-2422.
5. de Herder W, Hofland L, Usdin T, et al. 1996 Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. J Clin Endocrinol Metab. 81:3168-3172.
6. Hamet P, Larochelle P, Franks D, P. C, Bolté E. 1987 Cushing syndrome with food-depeodent periodic hormonogenesis. Clin Invest Med. 10:530-533.
7. Perraudin V, Delarue C, DeKeyser Y, et al. 1995 Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in vivo and in vitro studies. J Clin Endocrinol Metab. 80:2661-2667.
8. Lida K, Kaji H, Matsumoto H, et al. 1997 Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide. Clin Endocrinol (Oxf). 47:739-745.
9. N'Diaye N, Tremblay J, Harnet P, de Herder W, Lacroix A. 1998 Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome. J Clin Endocrinol Metab. 83:2781-2785.
10. Mountjoy K, Robbins L, Mortrud M, Cone R. 1992 The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1248-1251.
11. Chabre O, Comillon F, Bottari SP, Chambaz EM, Vilgrain I. 1995 Hormonal regulation of MAP kinase activity in bovine adrenocortical cells: cross-talk between phosphoinositides, cAMP, and tyrosine kinase receptor pathways. Endocrinology. 136:956-964.
12. Chomczynski P, Sacchi N. 1987 Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156-159.
13. Volz A, Göke R, Lankat-Buttgereit B, Fehman H-C, Bode H, Göke B. 1995 Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma. FEBS Lett. 373:23-29.
14. Gallagher R, McClean P, Malik A. 1994 Cloning and nucleotide sequence of a full length cDNA encoding ribosomal proteio L27 from human fetal kidney. Biochim Biophys Acta. 329-332.
15. Sambrook J, Fritsch E, Maniatis T. 1989 Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory; 9.49.
16. Usdin T, Mezey E, Button D, Brownstein M, Bonner T. 1993 Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology. 133:2861-2870.
17. Marshall C. 1995 Specificity of receptor tyrosine kinase signaling: transient vs. sustained extracellular signal-regulated kinase activation. Cell. 80:179-185.
18. van Biesen T, Hawes BE, Luttrell DK, et al. 1995 Receptor-tyrosine-kinase- and Gβγ-mediated MAP kinase activation by a commun signalling pathway. Nature. 376:781-784.
19. Dumont JE, Jauniaux JC, Roger PP. 1989 The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem. Sci. 14:67-71.
20. 5α genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab. 82:2695-2701.
21. Lyons J, Landis C, Harsh G, et al. 1990 Two G prutein oncogenes in human endocrine tumors. Science. 249:655-659.
22. Latronico A, Reincke M, Mendonca B, et al. 1995 No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. J Clin Endocrinol Metab. 80:875-877.
23. Light K, Jenkins P, Weber A, et al. 1995 Are activating mutations of the adrenocorticotropin receptor involved in adrenal cortical neoplasia? Life Sci. 56:1523-1527.
24. Reincke M, Karl M, Travis W, Chrousos G. 1993 No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms. J Clin Endocrinol Metab. 77:1419-1422.
25. Weinstein L, Shenker L, Gejman P, Merino M, Friedman E, Spiegel A. 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 325:1688-1695.
26. Boston B, Mandel S, LaFranchi S, Bliziotes M. 1994 Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia. J Clin Endocrinol Metab. 79:890-893.
27. Gicquel C, Dib A, Bertagna X, Amselem S, Le Bouc Y. 1995 Oncogenic mutations of Gi2-a protein are not determinant for human adrenocortical tumorigenesis. Eur J Endocrinol. 133:166-172.
28. Demeure M, Doffek K, Komorowski R, Gorski J. 1996 Gip-2 codon 179 oncogene mutations: absent in adrenal cortical tumors. World J Surg. 20:928-931.
29. Wheeler M, Gelling R, McIntosh C, Georgiou J, Brown J, Pederson R. 1995 Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties. Endocrinology. 136:4629-4639.
30. 2+/inositol phosphate signaling pathways. Mol Endocrinol. 6:551-556.
31. Abou-Samra A-B, Jüppner H, Force T, et al. 1992 Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci USA. 89:2732-2736.
32. Chabre O, Conklin BR, Brandon S, Bourne HR, Limbird LE. 1994 Coupling of the α2A-adrenergic receptor to multiple G-Proteins: a simple approach for estimating receptor-G-protein coupling efficiency in a transient expression system. J Biol Chem. 269:5730-5734.
33. Liddle G, Island D, Meador C. 1962 Normal and abnormal regulation of corticotropin secretion in man. Recent Prog Horm Res. 18:125-166.
34. Sander M, Ganten D, Mellon S. 1994 Role of adrenal renin in the regulation of adrenal steroidogenesis by corticotropin. Proc Natl Acad Sci USA. 91:148-152.
35. Ramachandran J, Suyama A. 1975 Inhibition of replication of normal adrenocortical cells in culture by adrenocorticotropin. Proc Natl Acad Sci USA. 72:113-117.
36. Duperray A, Chambaz E. 1980 Effect of prostaglandin E1 and ACTH on proliferation and steroidogenic activity of bovine adreno-cortical cells in primary culture. J Steroid Biochem. 13:1359-1364.
37. Negoescu A, Labat-Moleur F, Defaye G, et al. 1995 Contribution of apoptosis to the phenotypic changes of bovine adrenocortical cells in primary culture. Mol Cell Endocrinol. 110:175-184.
38. Arola J, Heikkila P, Voutilainen R, Kahri A. 1993 Role of adenylate cyclase-cyclic AMP-dependent signal transduction in the ACTH-induced biphasic growth effect of rat adrenocortical cells in primary, culture. J Endocrinol. 139:451-461.
39. Frodin M, Peraldi P, Van-Obberghen E. 1994 Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem. 269:6207-6214.
40. Faure M, Voyno-Yasenetskaya TA, Bourne HR. 1994 cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem. 269:7851-7854.
41. Vossler M, Yao H, York H, Pan M-G, Rim C, Stork P. 1997 cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell. 89:73-82.
42. Calleja V, Enriquez P, Filloux C, Peraldi P, Baron V, Van Obberghen E. 1997 The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor. Endocrinology. 138:1111-1120.